Cargando…
API5 induces cisplatin resistance through FGFR signaling in human cancer cells
Most tumors frequently undergo initial treatment with a chemotherapeutic agent but ultimately develop resistance, which limits the success of chemotherapies. As cisplatin exerts a high therapeutic effect in a variety of cancer types, it is often used in diverse strategies, such as neoadjuvant, adjuv...
Autores principales: | Jang, Han Sol, Woo, Seon Rang, Song, Kwon-Ho, Cho, Hanbyoul, Chay, Doo Byung, Hong, Soon-Oh, Lee, Hyo-Jung, Oh, Se Jin, Chung, Joon-Yong, Kim, Jae-Hoon, Kim, Tae Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628271/ https://www.ncbi.nlm.nih.gov/pubmed/28883546 http://dx.doi.org/10.1038/emm.2017.130 |
Ejemplares similares
-
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
por: Son, Sung Wook, et al.
Publicado: (2022) -
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
por: Song, Kwon-Ho, et al.
Publicado: (2020) -
Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2019) -
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
por: Oh, Se Jin, et al.
Publicado: (2023) -
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
por: Song, Kwon-Ho, et al.
Publicado: (2017)